ABOUT THE 5TH ANNUAL IMMUNO-ONCOLOGY FORUM
Taking place on the first day of ASCO, the 5th Annual Immuno-Oncology BD&L and Investment Forum is designed to bring together thought leaders from cancer research institutes, patient advocacy groups, pharma and biotech to facilitate partnering, funding and investment. We expect over 200 delegates and around 25 presentations by listed and private biotechnology companies seeking licensing & investment.